TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT04592159

Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder

Cause of deathStaffing, sites or logistics Automatic label, confidence 0.9, unverified. How labels are made.
“The decision to suspend this study was based upon evaluation of pandemic-related challenges impacting both clinical trial sites and potential participants. This suspension was initiated prior to site activation and participant recruitment.”

The sponsor’s own words in the registry.

Life of this trial

2020202120222023Registered2020-10-07Planned start2021-02-01 (planned)Withdrawn (as of)2022-06-03

Vital statistics

Status
Withdrawn
Phase
Phase 2, Phase 3
Sponsor
Jazz Pharmaceuticals
Sponsor type
Industry
Conditions
Post-Traumatic Stress Disorder
Interventions
Nabiximols; Placebo
Participants
0

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.